Component E-C with Tylan

Restrain The Animal

Speed of implantation as well as safety of handlers is best achieved by restraining animal in a squeeze chute using head restraint.

Prepare The Implant Site

Scrub the back side of the ear (implant site) with a piece of clean absorbent cotton or brush which has been soaked with topical germicidal solution. Follow manufacturer’s directions on germicide for correct strength and preparation of solution. Avoid getting disinfectant in animal’s eyes.

Where To Implant

The full contents of one cartridge cell should be implanted beneath the skin on the back side of the middle one-third of the ear as illustrated in the drawing. The implant must not be closer to the head than the edge of the auricular cartilage ring farthest from the head. The location for insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site. Avoid injuring the large arteries, veins and cartilage of the ear.

Insert The Needle

With one hand firmly grasp the ear. With the other hand insert needle point through the skin and ease forward on a lateral plane until the entire length of the needle is under the skin.

Implant The Pellets

After inserting the needle fully in the correct implant position, squeeze the trigger fully as the needle is withdrawn from the ear. This properly deposits the implant in the needle track. This procedure should prevent breakage or crushing of pellets if otherwise forced into contact with tough fibrous-tissue underlying the skin. The length and total contact area of a single dose are designed to permit absorption of the hormones after implantation to stimulate good weight gain. Broken or crushed pellets may interfere with rates of gain and may lead to undesirable side effects such as noted in the CAUTION.

Clean The Needle

Clean the implanter needle with alcohol or a properly diluted germicidal solution prior to implanting the next animal.

Storage Conditions

Store at controlled room temperature 15° to 30°C (59° to 86°F)

Avoid excessive heat and humidity. Discard open foil pouches.

NADA 110-315, Approved by FDA

Manufactured by a non-sterilizing process.

Component E-C with Tylan (progesterone and estradiol and tylosin implant) is covered by U.S. Patent No. 5,874,098

Component, Tylan, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

Distributed by Elanco US Inc, Greenfield, IN 46140, USA

Tylosin: Product of United Kingdom

To report adverse events, access medical information, or to obtain additional product information, call 1-800-428-4441

PA100983X

AH0507

CPN: 1131051.0